This implies that passive immunization with tau antibodies is actually a practical therapeutic focus on and that the CSF volume of p-tau262/356 or with the microtubule binding domain (MTBD) can function a handy biomarker of tau pathology to observe tau therapeutics in scientific trials.Immerse oneself in TAU’s bold and emotionally charged works,